Eden G Robertson1,2, Claire E Wakefield3,4, Joanne Shaw5, Anne-Sophie Darlington6, Brittany C McGill3,4, Richard J Cohn3,4, Joanna E Fardell3,4. 1. Discipline of Pediatrics, School of Women's and Children's Health, UNSW Sydney, Kensington, NSW, Australia. eden.robertson@unsw.edu.au. 2. Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia. eden.robertson@unsw.edu.au. 3. Discipline of Pediatrics, School of Women's and Children's Health, UNSW Sydney, Kensington, NSW, Australia. 4. Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia. 5. Psycho-Oncology Co-operative Research Group (PoCoG), The University of Sydney, Camperdown, NSW, Australia. 6. Faculty of Health Sciences, University of Southampton, Southampton, United Kingdom.
Abstract
PURPOSE: Few studies have addressed the way in which families of children with cancer make treatment decisions, and how we can meet parents' and young peoples' decisional involvement needs. We aimed to explore parents' and adolescents' views and perceptions of making medical decisions in pediatric oncology. METHODS: We conducted semi-structured interviews with 25 parents of children diagnosed with cancer in the past 12 months, and 5 adolescents diagnosed in the past 12 months. Our interview schedule was underpinned by Elwyn and Miron-Shatz's decision-making model. The model acknowledges the deliberation (process of coming to a decision) and determination (making a choice) phases of decision-making. We conducted a thematic analysis. RESULTS: Our findings indicate that information provision is not enough to facilitate parents' decision-making involvement. Many parents sought additional information to meet their individual needs and preferences. While many parents and young people desired decisional involvement, they trusted the doctors to make treatment decisions. Feelings of distress, inadequacy, and lack of choice impacted decision-making participation. Regardless, many parents in our study were satisfied with treatment decisions, but this was largely dependent on positive treatment outcomes. CONCLUSION: Our study contributes to understanding how families of a child with cancer make treatment decisions. Families tend to rely on doctors to make treatment decisions, but often seek additional information to help them feel involved in the decision process. Findings highlight that decision-making in pediatric oncology should focus on involving families in the deliberation phase, rather than just determination of choice.
PURPOSE: Few studies have addressed the way in which families of children with cancer make treatment decisions, and how we can meet parents' and young peoples' decisional involvement needs. We aimed to explore parents' and adolescents' views and perceptions of making medical decisions in pediatric oncology. METHODS: We conducted semi-structured interviews with 25 parents of children diagnosed with cancer in the past 12 months, and 5 adolescents diagnosed in the past 12 months. Our interview schedule was underpinned by Elwyn and Miron-Shatz's decision-making model. The model acknowledges the deliberation (process of coming to a decision) and determination (making a choice) phases of decision-making. We conducted a thematic analysis. RESULTS: Our findings indicate that information provision is not enough to facilitate parents' decision-making involvement. Many parents sought additional information to meet their individual needs and preferences. While many parents and young people desired decisional involvement, they trusted the doctors to make treatment decisions. Feelings of distress, inadequacy, and lack of choice impacted decision-making participation. Regardless, many parents in our study were satisfied with treatment decisions, but this was largely dependent on positive treatment outcomes. CONCLUSION: Our study contributes to understanding how families of a child with cancer make treatment decisions. Families tend to rely on doctors to make treatment decisions, but often seek additional information to help them feel involved in the decision process. Findings highlight that decision-making in pediatric oncology should focus on involving families in the deliberation phase, rather than just determination of choice.
Authors: Kimberly S Miller; Kathryn Vannatta; Michael Vasey; Nicholas Yeager; Bruce E Compas; Cynthia A Gerhardt Journal: Pediatr Blood Cancer Date: 2012-03-20 Impact factor: 3.167
Authors: Justin N Baker; Angela C Leek; Halle Showalter Salas; Dennis Drotar; Robert Noll; Susan R Rheingold; Eric D Kodish Journal: Cancer Date: 2013-09-04 Impact factor: 6.860
Authors: Meaghann S Weaver; Justin N Baker; Jami S Gattuso; Deborah V Gibson; April D Sykes; Pamela S Hinds Journal: Cancer Date: 2015-09-08 Impact factor: 6.860
Authors: Bryan A Sisk; Kieandra Harvey; Annie B Friedrich; Alison L Antes; Lauren H Yaeger; Jennifer W Mack; James M DuBois Journal: Pediatr Blood Cancer Date: 2021-10-18 Impact factor: 3.167
Authors: Eden G Robertson; Claire E Wakefield; Maria Tsoli; Stewart J Kellie; Frank Alvaro; Andrew J Gifford; Martin A Weber; Michael Rodriguez; Maria Kirby; David S Ziegler Journal: Neurooncol Adv Date: 2021-08-25
Authors: Katie A Greenzang; Hasan Al-Sayegh; Clement Ma; Mehdi Najafzadeh; Eve Wittenberg; Jennifer W Mack Journal: Pediatrics Date: 2020-04-13 Impact factor: 7.124
Authors: Maria Eduarda Alves Sampaio; Isabella Lima Arrais Ribeiro; Bianca Marques Santiago; Ana Maria Gondim Valença Journal: Asian Pac J Cancer Prev Date: 2022-02-01
Authors: Malin de Flon; Gisela Glaffey; Linda Jarl; Kristin Sellbrant; Stefan Nilsson Journal: Int J Environ Res Public Health Date: 2021-06-09 Impact factor: 3.390
Authors: Nathan L Basile; Marie L Chardon; James Peugh; Clayton S Edwards; Lauren Szulczewski; Caroline F Morrison; Rajaram Nagarajan; Ayman El-Sheikh; John M Chaney; Ahna L H Pai; Larry L Mullins Journal: J Pediatr Psychol Date: 2021-10-18
Authors: Anne-Sophie E Darlington; Jessica E Morgan; Richard Wagland; Samantha C Sodergren; David Culliford; Ashley Gamble; Bob Phillips Journal: Pediatr Blood Cancer Date: 2020-11-21 Impact factor: 3.838